Mitapivat 10 mg | 99.81%
TargetMol
Mitapivat, also known as PKM2 activator 1020 is a PKM2 activator (pyruvate kinase activator) for the treatment of pyruvate kinase deficiency.
More Information Supplier PageMitapivat
Search Results
GW 441756 25 mg | Purity Not Available
TargetMol
GW 441756 is a specific Tropomyosin-related kinase A (TrkA) inhibitor with an IC50 value of 2 nM.
More Information Supplier PageGW 441756
GW 441756 10 mg | Purity Not Available
TargetMol
GW 441756 is a specific Tropomyosin-related kinase A (TrkA) inhibitor with an IC50 value of 2 nM.
More Information Supplier PageGW 441756
Linsitinib 5 mg | 98.00%
TargetMol
OSI-906 (Linsitinib) is an orally bioavailable small molecule inhibitor of the insulin-like growth factor 1 receptor (IGF-1R) with potential antineoplastic activity. Linsitinib selectively inhibits IGF-1R, which may result in the inhibition of tumor cell proliferation and the induction of tumor cell apoptosis. Overexpressed in a variety of human cancers, IGF-1R stimulates cell proliferation, enables oncogenic […]
More Information Supplier PageLinsitinib
Linsitinib 50 mg | 98.00%
TargetMol
OSI-906 (Linsitinib) is an orally bioavailable small molecule inhibitor of the insulin-like growth factor 1 receptor (IGF-1R) with potential antineoplastic activity. Linsitinib selectively inhibits IGF-1R, which may result in the inhibition of tumor cell proliferation and the induction of tumor cell apoptosis. Overexpressed in a variety of human cancers, IGF-1R stimulates cell proliferation, enables oncogenic […]
More Information Supplier PageLinsitinib
Linsitinib 10 mg | 98.00%
TargetMol
OSI-906 (Linsitinib) is an orally bioavailable small molecule inhibitor of the insulin-like growth factor 1 receptor (IGF-1R) with potential antineoplastic activity. Linsitinib selectively inhibits IGF-1R, which may result in the inhibition of tumor cell proliferation and the induction of tumor cell apoptosis. Overexpressed in a variety of human cancers, IGF-1R stimulates cell proliferation, enables oncogenic […]
More Information Supplier PageLinsitinib
Mitapivat 5 mg | 99.81%
TargetMol
Mitapivat, also known as PKM2 activator 1020 is a PKM2 activator (pyruvate kinase activator) for the treatment of pyruvate kinase deficiency.
More Information Supplier PageMitapivat
Glutaminase C-IN-1 50 mg | 99.82%
TargetMol
Glutaminase C-IN-1
Glutaminase C-IN-1 5 mg | 99.82%
TargetMol
Glutaminase C-IN-1
MSX-130 10 mg | 99.44%
TargetMol
MSX-130
